EBITDA společnosti 180 Life Sciences
Jaká je hodnota metriky EBITDA společnosti 180 Life Sciences?
Hodnota metriky EBITDA společnosti 180 Life Sciences Corp. je -$16.63
Jaká je definice metriky EBITDA?
EBITDA je zisk před odečtením úroků, daní, odpisů a amortizací udávající operační výkonnost společnosti.
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
EBITDA společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností 180 Life Sciences
Čemu se věnuje společnost 180 Life Sciences?
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
Firmy s metrikou ebitda podobnou společnosti 180 Life Sciences
- Hodnota metriky EBITDA společnosti Siyata Mobile je -$16.69
- Hodnota metriky EBITDA společnosti Galway Metals je -CAD$16.69
- Hodnota metriky EBITDA společnosti Galway Metals je -CAD$16.69
- Hodnota metriky EBITDA společnosti Amicus Therapeutics Inc je -$16.68
- Hodnota metriky EBITDA společnosti Bionomics je -AUD$16.68
- Hodnota metriky EBITDA společnosti Redx Pharma Plc je -£16.65
- Hodnota metriky EBITDA společnosti 180 Life Sciences je -$16.63
- Hodnota metriky EBITDA společnosti F-Secure Oyj je -€16.57
- Hodnota metriky EBITDA společnosti Aleafia Health Inc je -CAD$16.57
- Hodnota metriky EBITDA společnosti Clarus Corp je -$16.56
- Hodnota metriky EBITDA společnosti Ioneer je -AUD$16.55
- Hodnota metriky EBITDA společnosti Limeade je -$16.52
- Hodnota metriky EBITDA společnosti American Resources je -$16.52